Use of glucagon-like peptide-1 receptor agonists in patients with left ventricular assist devices. [PDF]
Ibrahim R +12 more
europepmc +1 more source
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonists. [PDF]
Marshall LZ +4 more
europepmc +1 more source
Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety. [PDF]
Chao AM, Gilden A, Wadden TA.
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonists and Hepatocellular Carcinoma Prevention: A Meta-Analysis and Clinical Decision Framework. [PDF]
Dalbeni A +9 more
europepmc +1 more source
The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition. [PDF]
Chrysavgis L +4 more
europepmc +1 more source
Evaluating the Effects of Glucagon-Like Peptide 1 Receptor Agonists as a Secondary Prevention in Peripheral Arterial Disease: A Meta-Analysis. [PDF]
Elliott B +6 more
europepmc +1 more source
Weight Loss in Primary Total Hip and Knee Arthroplasty: A Comparative Study of Glucagon-Like Peptide-1 Receptor Agonists and Bariatric Surgery. [PDF]
Ledford CK +7 more
europepmc +1 more source
The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe? [PDF]
Kounatidis D +6 more
europepmc +1 more source

